Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 20 studies | 45% ± 22% | |
lung | 19 studies | 32% ± 11% | |
peripheral blood | 17 studies | 34% ± 10% | |
intestine | 10 studies | 25% ± 11% | |
eye | 10 studies | 42% ± 18% | |
kidney | 9 studies | 29% ± 10% | |
liver | 6 studies | 39% ± 17% | |
heart | 5 studies | 34% ± 7% | |
breast | 5 studies | 24% ± 6% | |
bone marrow | 4 studies | 28% ± 10% | |
uterus | 4 studies | 30% ± 12% | |
lymph node | 4 studies | 27% ± 5% | |
adipose | 4 studies | 43% ± 13% | |
pancreas | 3 studies | 48% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6897.54 | 1445 / 1445 | 100% | 46.62 | 183 / 183 |
prostate | 100% | 7211.88 | 245 / 245 | 100% | 26.97 | 502 / 502 |
thymus | 100% | 7657.91 | 653 / 653 | 100% | 28.41 | 604 / 605 |
brain | 100% | 5742.02 | 2641 / 2642 | 100% | 26.70 | 704 / 705 |
uterus | 100% | 8520.94 | 170 / 170 | 100% | 19.66 | 458 / 459 |
intestine | 100% | 8053.06 | 966 / 966 | 100% | 28.28 | 525 / 527 |
pancreas | 100% | 3790.74 | 328 / 328 | 99% | 21.04 | 177 / 178 |
breast | 100% | 7017.65 | 459 / 459 | 99% | 33.27 | 1109 / 1118 |
ovary | 100% | 7496.22 | 180 / 180 | 99% | 19.63 | 426 / 430 |
lung | 100% | 6642.09 | 578 / 578 | 99% | 25.86 | 1144 / 1155 |
stomach | 100% | 6500.41 | 359 / 359 | 99% | 37.65 | 283 / 286 |
skin | 100% | 7407.85 | 1809 / 1809 | 98% | 22.91 | 463 / 472 |
bladder | 100% | 7884.05 | 21 / 21 | 98% | 19.77 | 494 / 504 |
kidney | 100% | 6135.52 | 89 / 89 | 98% | 26.48 | 883 / 901 |
adrenal gland | 100% | 5444.37 | 258 / 258 | 89% | 12.00 | 204 / 230 |
liver | 100% | 4108.72 | 226 / 226 | 81% | 10.66 | 330 / 406 |
adipose | 100% | 6592.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7821.67 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 18.11 | 29 / 29 |
muscle | 100% | 6965.92 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6041.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.42 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.11 | 1 / 1 |
heart | 98% | 3701.20 | 847 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 5093.59 | 909 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 16.45 | 77 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0045475 | Biological process | locomotor rhythm |
GO_1902894 | Biological process | negative regulation of miRNA transcription |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045820 | Biological process | negative regulation of glycolytic process |
GO_0045922 | Biological process | negative regulation of fatty acid metabolic process |
GO_0051225 | Biological process | spindle assembly |
GO_0046329 | Biological process | negative regulation of JNK cascade |
GO_0060766 | Biological process | negative regulation of androgen receptor signaling pathway |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0072686 | Cellular component | mitotic spindle |
GO_0016020 | Cellular component | membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0017053 | Cellular component | transcription repressor complex |
GO_0000118 | Cellular component | histone deacetylase complex |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0046966 | Molecular function | nuclear thyroid hormone receptor binding |
GO_0016922 | Molecular function | nuclear receptor binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | NCOR1 |
Protein name | Nuclear receptor corepressor 1 Nuclear receptor corepressor 1 (N-CoR) (N-CoR1) |
Synonyms | KIAA1047 |
Description | FUNCTION: Mediates transcriptional repression by certain nuclear receptors . Part of a complex which promotes histone deacetylation and the formation of repressive chromatin structures which may impede the access of basal transcription factors. Participates in the transcriptional repressor activity produced by BCL6. Recruited by ZBTB7A to the androgen response elements/ARE on target genes, negatively regulates androgen receptor signaling and androgen-induced cell proliferation . Mediates the NR1D1-dependent repression and circadian regulation of TSHB expression (By similarity). The NCOR1-HDAC3 complex regulates the circadian expression of the core clock gene ARTNL/BMAL1 and the genes involved in lipid metabolism in the liver (By similarity). . |
Accessions | Q3B773 S4R380 ENST00000603989.1 Q86W52 ENST00000436828.5 A0A994J5B8 ENST00000704744.1 ENST00000582357.5 A5PKW7 ENST00000460276.5 ENST00000430577.2 O75376 ENST00000395851.5 [O75376-2] ENST00000268712.8 [O75376-1] Q05CG3 Q6PDT8 ENST00000579573.2 C9JAP0 ENST00000580554.1 J3KT44 E7EVK1 J3QKP0 ENST00000579606.1 J3KS29 ENST00000436068.2 H0Y459 ENST00000411510.5 Q6NTH1 ENST00000395849.6 ENST00000395848.5 [O75376-3] Q6PGR4 E7EW50 E7EVU5 ENST00000704745.1 J3KRE4 J3KS51 |